Introduction of an aliphatic side chain to a key position of a novel piperidine-based HDM2 inhibitor scaffold resulted in significant potency gains, enabling further series progression.
Keywords: HDM2; MDM2; p53; protein−protein interaction; small molecule inhibitor; substituted piperidine.